You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Liposomal Irinotecan Safety Reminder

Version: 1 ID: GL-C50-35 Sep 2017
Type of Content: Drug Safety, Guidelines & Advice, Clinical
Document Status: Current
Authors:
CCO Systemic Treatment

Guideline Objective

The Systemic Treatment Program would like to remind healthcare providers to be vigilant against potential medication errors with liposomal irinotecan.

Intended Guideline Users

Health care professionals (MDs, nurses, pharmacists)

pdf download Full Report (PDF) (101.28 KB)